Partners
Our existing partnerships are listed below. Britannia would be interested in partnering or in-licensing other opportunities within the Parkinson's disease or movement disorder field. If you would like further information regarding potential partnership opportunities, please contact us.
Click on logos below to visit our partners websites.
APO (apomorphine hydrochloride)
Country |
Partner |
|
Australia & New Zealand |
Hospira |
|
|
||
Austria |
Cephalon |
 |
|
||
Baltic States |
Wansår Corporation |
|
|
||
Canada |
Ipsen |
 |
|
||
Denmark |
NordicInfu Care |
 |
|
||
Germany |
Cephalon |
|
|
||
Greece |
ITF Hellas |
|
|
||
Hong Kong |
Stada Asia |
|
|
||
Israel |
Teva |
 |
|
||
Japan |
Kyowa Hakko Kirin |
 |
|
||
Netherlands |
ApotheekZorg |
 |
|
||
North America |
Ipsen |
|
|
||
Portugal |
Italfarmaco |
 |
|
||
Republic of Ireland |
Clonmel Healthcare |
 |
|
||
Spain |
Italfarmaco |
|
|
||
Sweden |
NordicInfu Care |
|
Turkey |
Gen Ilac |
 |
|
||
UK |
Genus Pharmaceuticals |
 |
|
||
Venezula |
Venfarma |
 |
|
||
BritLofex (Lofexidine)
Austria & Switzerland |
AOP Orphan |
 |
|
||
Republic of Ireland |
Clonmel Healthcare |
|
|
||
CT |
Italy |
 |
North America |
US World Meds |
 |
